243 related articles for article (PubMed ID: 26359565)
1. Progressing Sclerosing Mesenteritis (Mesenteric Panniculitis) Mimics Progression of Malignancy After Neoadjuvant Chemotherapy for Gastric Adenocarcinoma on Serial 18F-FDG PET/CT.
Makis W
Clin Nucl Med; 2016 Apr; 41(4):313-6. PubMed ID: 26359565
[TBL] [Abstract][Full Text] [Related]
2. F-18 FDG PET demonstration of sclerosing mesenteritis.
Nguyen BD
Clin Nucl Med; 2003 Aug; 28(8):670-1. PubMed ID: 12897656
[TBL] [Abstract][Full Text] [Related]
3. Mesenteric Panniculitis Demonstrated on 18F-FDG PET/CT.
Albano D; Bosio G; Bertagna F
Clin Nucl Med; 2016 Mar; 41(3):e164-6. PubMed ID: 26462046
[TBL] [Abstract][Full Text] [Related]
4. FDG-PET/CT assessment of misty mesentery: feasibility for distinguishing viable mesenteric malignancy from stable conditions.
Nakatani K; Nakamoto Y; Togashi K
Eur J Radiol; 2013 Aug; 82(8):e380-5. PubMed ID: 23619310
[TBL] [Abstract][Full Text] [Related]
5. Gastric recurrence of a primary colon plasmacytoma: staging and evaluating response to therapy with 18F-FDG PET/CT.
Makis W; Ciarallo A; Hickeson M; Lisbona R
Br J Radiol; 2012 Jan; 85(1009):e4-9. PubMed ID: 22190759
[TBL] [Abstract][Full Text] [Related]
6. Sclerosing mesenteritis mimicking metachronous peritoneal metastases from descending colon adenocarcinoma.
Watanabe T; Terai S; Tsukada T; Takeshita M; Matsui K; Amaya K; Kaji M; Maeda K; Shimizu K; Saito J; Mochizuki K; Uchiyama A
World J Surg Oncol; 2017 Aug; 15(1):142. PubMed ID: 28764712
[TBL] [Abstract][Full Text] [Related]
7. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
Cuellar SL; Carter BW; Macapinlac HA; Ajani JA; Komaki R; Welsh JW; Lee JH; Swisher SG; Correa AM; Erasmus JJ; Hofstetter WL
J Thorac Oncol; 2014 Aug; 9(8):1202-6. PubMed ID: 25157774
[TBL] [Abstract][Full Text] [Related]
8. Mesenteric panniculitis in oncologic patients: PET-CT findings.
Zissin R; Metser U; Hain D; Even-Sapir E
Br J Radiol; 2006 Jan; 79(937):37-43. PubMed ID: 16421403
[TBL] [Abstract][Full Text] [Related]
9. A hepatoid adenocarcinoma of the stomach evaluated with (18)F-FDG PET/CT: intense (18)F-FDG uptake contrary to the previous report.
Seo HJ; Chung JK; Go H; Cheon GJ; Lee DS
Clin Nucl Med; 2014 May; 39(5):442-5. PubMed ID: 24152637
[TBL] [Abstract][Full Text] [Related]
10. Is there a role for PET/CT with esophagogastric junction adenocarcinoma?
Fuster D; Mayoral M; Rubello D; Pineda E; Fernández-Esparrach G; Pagès M; Colletti PM; Pons F
Clin Nucl Med; 2015 Mar; 40(3):e201-7. PubMed ID: 25546207
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of gastric malignancy on 18F-FDG PET/CT: a pictorial essay.
Makis W; Ciarallo A; Hickeson M; Rush C; Derbekyan V; Novales-Diaz JA; Laufer J; Stern J; Lisbona R
Clin Imaging; 2012; 36(5):432-46. PubMed ID: 22920343
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDG PET/CT Findings in a Patient With IgG4-Related Sclerosing Mesenteritis.
Fu Z; Chen G; Liu M; Li Z; Li Q
Clin Nucl Med; 2018 Apr; 43(4):294-295. PubMed ID: 29432345
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of incidental colonic 18F-FDG uptake on PET/CT images in patients with gastric adenocarcinoma.
Shim JH; O JH; Oh SI; Yoo HM; Jeon HM; Park CH; Kim SH; Song KY
J Gastrointest Surg; 2012 Oct; 16(10):1847-53. PubMed ID: 22752472
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET/CT of Primary Mediastinal Hepatoid Adenocarcinoma.
Hu N; Tan Y; Luo J; Cheng Z; Wang Y
Clin Nucl Med; 2016 Apr; 41(4):321-2. PubMed ID: 26914554
[TBL] [Abstract][Full Text] [Related]
15. A rare case of synchronous fetal type adenocarcinoma and mucinous adenocarcinoma of the lung evaluated by 18F-FDG PET/CT.
Paone G; Treglia G; Bongiovanni M; Ceriani L; Giovanella L
Clin Nucl Med; 2014 Aug; 39(8):e384-6. PubMed ID: 23877519
[TBL] [Abstract][Full Text] [Related]
16. [Malignant tumor with false negative 18F-FDG PET image].
Dong MJ; Lin XT; Zhao J; Guan YH; Zuo CT; Chen X; Dai JZ; Jiang BD
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):713-7. PubMed ID: 17274383
[TBL] [Abstract][Full Text] [Related]
17. Detection of synchronous gastric schwannoma on FDG PET/CT aided by discordant metabolic response.
Yap J; Huang YT; Lin M
Clin Nucl Med; 2015 May; 40(5):e287-9. PubMed ID: 25706785
[TBL] [Abstract][Full Text] [Related]
18. Bilateral ovarian metastases from gastric carcinoma on FDG PET/CT.
Ho L; Wassef H; Nakla A; Henderson R
Clin Nucl Med; 2012 May; 37(5):524-7. PubMed ID: 22475913
[TBL] [Abstract][Full Text] [Related]
19. [18F]-fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemotherapy in gastric cancer.
Vallböhmer D; Hölscher AH; Schneider PM; Schmidt M; Dietlein M; Bollschweiler E; Baldus S; Alakus H; Brabender J; Metzger R; Mönig SP
J Surg Oncol; 2010 Aug; 102(2):135-40. PubMed ID: 20648583
[TBL] [Abstract][Full Text] [Related]
20. A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer.
Smyth E; Schöder H; Strong VE; Capanu M; Kelsen DP; Coit DG; Shah MA
Cancer; 2012 Nov; 118(22):5481-8. PubMed ID: 22549558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
